Recovery of ovarian function and pregnancy in a patient with AML after myeloablative busulphan-based conditioning regimen.

Autor: Balashov DN; Federal Research and Clinical Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia. bala8@yandex.ru, Papusha LI, Nazarenko TA, Trakhtman PE, Revishvili NA, Maschan AA, Persiantseva MI, Andriutsa AV, Skorobogatova EV, Skvortsova YV, Rumiantsev AG

Publikováno v: Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2011 May; Vol. 33 (4), pp. e154-5.